Back
Astria Therapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
48
ATXS
Astria Therapeutics, Inc.
Last Price:
$12.56
Seasonality Move:
-10.52%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.Astria Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Astria Therapeutics, Inc. has on average historically fallen by 4.6% based on the past 10 years of stock performance.
-
Astria Therapeutics, Inc. has fallen lower in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Astria Therapeutics, Inc. Stock Undervalued?The current Astria Therapeutics, Inc. [ATXS] share price is $12.58. The Score for ATXS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ATXS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Astria Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Astria Therapeutics, Inc. has on average historically fallen by 4.6% based on the past 10 years of stock performance.
Astria Therapeutics, Inc. Stock Rating
Sell
48
Astria Therapeutics, Inc. (ATXS)
is a Sell
Is Astria Therapeutics, Inc. overpriced?
-
Astria Therapeutics, Inc. has fallen lower in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Astria Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
astriatx.com
52-Week Data
52-Week High:
13.29
52-Week Low:
3.56
Prediction Charts
Market Cap:
718.1M
Price in USD:
12.58
Volume:
3.2M
Beta:
1.10
Technical Analysis
SMA50:
12.73
SMA100:
10.90
SMA200:
8.20
52-Wk Change:
67.73%
Stock Predictions
-
Is Astria Therapeutics, Inc. stock public?Yes, Astria Therapeutics, Inc. is a publicly traded company.
-
What is the Astria Therapeutics, Inc. stock quote today?The Astria Therapeutics, Inc. stock price is 12.58 USD today.
-
How to buy Astria Therapeutics, Inc. stock online?You can buy Astria Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 13.00 | 13.09 | 13.13 | 12.97 |
| Jan-5 | 12.86 | 12.82 | 12.91 | 12.73 |
| Jan-6 | 12.78 | 12.93 | 12.97 | 12.78 |
| Jan-7 | 13.00 | 13.20 | 13.29 | 13.00 |
| Jan-8 | 13.16 | 12.98 | 13.16 | 12.95 |
| Jan-9 | 13.00 | 12.88 | 13.27 | 12.88 |
| Jan-12 | 12.92 | 12.72 | 12.92 | 12.64 |
| Jan-13 | 12.74 | 12.51 | 12.74 | 12.49 |
| Jan-14 | 12.50 | 12.54 | 12.58 | 12.50 |
| Jan-15 | 12.55 | 12.81 | 12.86 | 12.45 |
| Jan-16 | 12.81 | 12.47 | 12.81 | 12.41 |
| Jan-20 | 12.30 | 12.44 | 12.50 | 12.24 |
| Jan-21 | 12.41 | 12.50 | 12.51 | 12.41 |
| Jan-22 | 12.48 | 12.58 | 12.59 | 12.45 |
Astria Therapeutics, Inc. Earnings
Astria Therapeutics, Inc. Earnings Report: Per Share Astria Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Astria Therapeutics, Inc. Forecast Revenue Growth
Astria Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Astria Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.32 per share.
* Astria Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.